Not rendering correctly? View this email as a web page here.
Newsletter Header - June 2019
Newsletter_Green_Divider_with_White_Space.png

Artificial Intelligence and Machine Learning: Innovations in Clinical Trial Data Automation

DIA Innovation Theater, June 24 at 5:30pm PDT

With a focus toward achieving faster time to market, reducing R&D costs, and increasing clinical trial success rates, Artificial Intelligence (AI) and Machine Learning (ML) capabilities are quickly becoming the next frontier in clinical research. In this Innovation Theater presentation at DIA 2019, SDC will share an overview of AI/ML applications in clinical trials, a case study featuring AI/ML deployment in clinical data services, and several lessons learned to help you integrate AI/ML capabilities in your clinical trials.

Presented by Dale W. Usner, Ph.D. (CSO & Sr. VP, Strategic Scientific Consulting) and Richard B. Abelson, Ph.D. (President & CEO)

About DIA 2019

Newsletter_Green_Divider_with_White_Space.png

SDC Sponsors Medical Heroes Appreciation 5K Run & Walk

5K at DIA, June 24 at 6:30am PDT

SDC is proud to sponsor the 6th Annual Medical Heroes Appreciation 5K Run & Walk at DIA in San Diego, CA. Organized by CISCRP, a non-profit organization dedicated to educating and engaging the public as partners in the clinical research process, the Medical Heroes Appreciation 5K celebrates the study volunteers who give the gift of participation in clinical research. All proceeds provide education and outreach about clinical research participation to patients and their families in minority and under-served communities.

About the 5K

Newsletter_Green_Divider_with_White_Space.png

Best Practices for ISS/ISE Dataset Development

Bharath Donthi to Present at PharmaSUG 2019

SDC is proud to announce that Bharath Donthi, Associate Director, SAS Programming, has been selected to present his paper on "Best Practices for ISS/ISE Dataset Development" at the PharmaSUG 2019 annual conference on Tuesday, June 18 at 1:30pm in Philadelphia, PA.

The integrated summary of safety (ISS) and integrated summary of efficacy (ISE) are vital components of a successful submission for regulatory approval in the pharmaceutical industry. ISS/ISE allows reviewers to easily compare individual outcomes and facilitates broad views of the investigational product's overall efficacy and safety profiles. However, building integrated datasets is a challenging task as it requires the programmer to achieve consistent structures and formats while also ensuring that each dataset is CDISC-compliant. This presentation will highlight best practices for the efficient and accurate creation of ISS/ISE datasets. 

About PharmaSUG 2019
Newsletter_Green_Divider_with_White_Space.png

Automating SAS Program Table of Contents for Your FDA Submission Package

Lingjiao Qi to Present at PharmaSUG 2019

SDC is proud to announce that Lingjiao Qi, Ph.D., Senior Statistical Programmer, has been selected to present her paper on "Automating SAS Program Table of Contents for Your FDA Submission Package" at the PharmaSUG 2019 annual conference on Wednesday, June 19 at 9:30am in Philadelphia, PA.

Organizing SAS programs into a Table of Contents is highly recommended for FDA data submission packages; however, this is typically a manual and error-prone process. To increase accuracy and efficiency, SDC has developed an in-house macro tool to automatically generate a Table of Contents by reading each submitted SAS program and its associated files. This presentation will provide a detailed description of SDC's time-saving macro tool to assist SAS users in automatically generating the Table of Contents for their FDA data submission packages.

About PharmaSUG 2019
Newsletter_Green_Divider_with_White_Space.png

Employee Spotlight 

Lingjiao Qi, Ph.D.

Senior Statistical Programmer

lingjiao qi linkedin

Lingjiao joined SDC's Statistical Programming team in 2017 and has accrued several accolades since. In addition to her upcoming presentation at PharmaSUG 2019, Lingjiao presented at the Western Users of SAS Software (WUSS) conference in September 2018 and won a New SAS Professional Award at the event. She has co-authored four papers in her time here at SDC.

Prior to joining SDC, she held statistical programming roles at SynteractHCR in Carlsbad, CA and ResearchPointGlobal in Austin, TX. Her experience spans several therapeutic areas including, but not limited to: hepatology, neurology, oncology, ophthalmology, and women's health. Lingjiao specializes in complex programming projects and CDISC-compliant SDTM and ADaM implementation. When she's not working on client deliverables, Lingjiao can be found training junior programmers, improving our global library, and working on abstracts and papers for industry conferences.

Lingjiao holds a Ph.D. in Analytical Chemistry from North Carolina State University in Raleigh, NC and a Bachelor of Science in Chemistry from Beijing Normal University in Beijing, China. She is a SAS® Certified Base Programmer, SAS® Certified Advanced Programmer, and SAS® Certified Clinical Trials Programmer using SAS® 9. Lingjiao is an active member of the CDISC ADaM team.

Based in SDC's Tempe, AZ office, Lingjiao enjoys spending time with her husband and friends, which includes working out at the gym, hiking in trails, cooking at home, and traveling together to new places.

Interested in joining our team? View our open careers and apply online today!

Newsletter_Green_Divider_with_White_Space.png

Upcoming Events

We look forward to seeing you at one of the following events.

Conferences & Meetings

June 5-7, Sitges, Spain
 
June 23-27, San Diego, CA 
 
July 10-11, Irvine, CA  
 
 
Newsletter_Green_Divider_with_White_Space.png
SDC Newsletter Footer.png
Share this Newsletter or Forward to a Colleague:
   

63 South Rockford Drive, Suite 240Tempe, AZ  85281  United States

200 5th Avenue, Suite 2010, Waltham, MA  02451  United States

You received this email because you are subscribed to Newsletter from Statistics & Data Corporation (SDC).

Update your email preferences to choose the types of emails you receive.

 Unsubscribe from all future emails